Researchers launch first-ever phase II safety study of a rectal microbicide to prevent HIV

PITTSBURGH, Oct. 2, 2013 – Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal microbicide. The trial, led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network […]